Ricks Renews PhRMA Call For Comprehensive Japan Policy Dialog
'Transparency And Predictability' Needed
US research-based group again calls for a comprehensive dialog with all healthcare system stakeholders in Japan to address what it sees as "harmful" policies that have reduced the country's support for innovation and attractiveness as a market for drug development amid the rapid rise of some regional neighbors.
